Gojji Announces Partnership with PerformRx to Provide Chronic Disease Management Products and Services

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

Today Gojji, a data-driven chronic care management company, announced they have partnered with PerformRx, a URAC and NCQA-accredited full-service pharmacy benefit manager (PBM), to provide state-of-the-art chronic disease management products and best in class clinical services for their clients. This partnership will allow Gojji to provide turnkey services through its integration with PerformRx’s innovative product and service offerings.

Gojji shares the same vision and mission as PerformRx in using innovation to improve member outcomes and lower overall medical costs. Gojji’s comprehensive services provide continuous monitoring and intervention, which help bridge the gaps created by the enormous financial burden of chronic diseases where inappropriate medication use is very common. Their remote monitoring capability adds to the strength in delivering chronic disease management and medication optimization, and this has proven valuable, especially in times like today’s COVID-19 pandemic.

“We are very excited to join forces with PerformRx and offer our clinical services to their clients,” said Chris Chan, PharmD, Co-Founder and Chief Clinical Officer of Gojji. “Our clinical services have proven to save cost for our clients while improving outcomes for our patients. We are able to do this by combining technology and the expertise of our pharmacists and dietitians in a cost-effective manner. Our ultimate goal is to provide exceptional clinical service values to our health plan partners and our optional value-based payment model shows how confident we are in our product.”



Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.